Hervor Therapeutics
Clinical trials sponsored by Hervor Therapeutics, explained in plain language.
-
Experimental cell therapy for advanced tumors shows early promise
Disease control TerminatedThis early-phase study tested a new treatment called HV-101 for people with advanced solid tumors that had come back or spread. The treatment uses a patient's own immune cells (TILs) taken from their tumor, grown in a lab, and then given back to fight the cancer. The study was st…
Phase: PHASE1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Personalized cell therapy shows promise for Hard-to-Treat cancers
Disease control TerminatedThis study tested a personalized treatment called TIL therapy for people with advanced solid tumors. Doctors took immune cells from the patient's own tumor, grew them in a lab, and then put them back into the patient to attack the cancer. The goal was to see if this approach is s…
Phase: PHASE1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:49 UTC